Navigation Links
Onyx Pharmaceuticals Presents Carfilzomib Data at 53rd American Society of Hematology Annual Meeting
Date:12/12/2011

reated patients. The primary endpoint was ORR and secondary endpoints included CBR, TTP, DOR, OS and safety.
  • The 003-A1 study was an open-label, single-arm Phase 2b trial. The trial evaluated 266 heavily-pretreated patients with relapsed and refractory multiple myeloma who had received at least two prior therapies, including bortezomib and either thalidomide or lenalidomide. Refractory disease was defined as less than or equal to a 25 percent response or progression during therapy, or progression within 60 days after completion of therapy.[ii]  The primary endpoint was ORR. Secondary endpoints included DOR, CBR, OS, TTP, PFS, and safety. 
  • The 007 study is an open-label Phase 1b/2 study. Results were reported from the dose-expansion phase of this ongoing study, which evaluated the safety and efficacy of a prolonged, 30-minute infusion of carfilzomib at a dose of 56mg/m(2). Endpoints included ORR, DOR, PFS, TTP, pharmacokinetics and safety.
  •  

    ASH Investor Teleconference
    Investigators and members of the Onyx management team will highlight data presented on carfilzomib featured at the 53rd ASH Annual Meeting and Exposition in San Diego, CA. The teleconference will begin at 10:00 a.m. PT on December 13, 2011.

    Interested parties may access the teleconference and the presentation that accompanies it on our website at:  

    http://www.onyx-pharm.com/investors/event-calendar

    or by dialing 847-585-4405 and using the passcode 31296220.  A replay of the presentation will be available on the Onyx website or by dialing 630-652-3042 and using the passcode 31296220# later in the day.  The replay will be available on the Onyx website until December 27, 2011.

    Carfilzomib Development Program
    Carfilzomib is being studied in several clinical trials either as a single-agent or in combi
    '/>"/>

    SOURCE Onyx Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
    10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
    11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2014)... -- Research and Markets  has announced the addition ... Market 2014-2018" report to their offering. ... that connect, support, or surround bones. There are several ... cartilage, fascia, and other fibrous tissues. Repetitive use, accidents, ... result in wear and tear in these tissues. Orthopedic ...
    (Date:8/28/2014)... 28, 2014 Reportlinker.com announces that a ... catalogue: North America Aesthetic Lasers and ... http://www.reportlinker.com/p02343466/North-America-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html North America ... 2020 Summary GlobalData,s new report, "North ... to 2020", provides key market data on the ...
    (Date:8/28/2014)... , Aug. 28, 2014 ... report is available in its catalogue: ... 2014-2024 http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-2014-2024.html ... – discover technological and commercial prospects What ... delivery market? Visiongain,s brand new report shows ...
    Breaking Medicine Technology:Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 4North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 6North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 7North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 8North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 9North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 10North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 11North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 12North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 13North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 14North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 15North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18
    ... , , FREEHOLD, N.J. , Feb. 3 ... it has engaged Morgan Joseph & Co. Inc., ... to maximize shareholder value with respect to Speedus Corp,s subsidiary, ... medical software to identify and classify suspected systolic and diastolic ...
    ... , HOUSTON and DALLAS , ... along with the company,s management, medical staff, and employees, are making multiple ... earthquake in Haiti . , In response to the magnitude ... million homeless, and over 195,000 awaiting medical attention, First Choice owner ...
    Cached Medicine Technology:Speedus Engages Morgan Joseph to Evaluate Strategic Alternatives for Zargis Subsidiary 2Speedus Engages Morgan Joseph to Evaluate Strategic Alternatives for Zargis Subsidiary 3First Choice ER to Donate Over $15,000 in Medical Supplies to Haitian Earthquake Victims 2
    (Date:8/30/2014)... Denver, Colorado (PRWEB) August 30, 2014 ... a method that keeps anxiety and panic attacks under ... "Panic Away" program review describes this new ... help sufferers control panic attacks and overcome general anxiety ... popular and successful is the fact that it can ...
    (Date:8/30/2014)... The term nutraceuticals is coined ... is a source of healthy-dietary supplements that are ... sources. Nutraceutical ingredients have certain curative effects that ... Nutraceutical health products include factors such as herbal ... Although nature is the most bountiful source for ...
    (Date:8/30/2014)... 30, 2014 The establishment and ... has been one of the main strategies of ... a positive impact around the world. , Architecturally ... top trained executives and trainers deliver L. Ron ... Vital statistics demonstrate that significant reduction in ...
    (Date:8/30/2014)... Dallas, TX (PRWEB) August 30, 2014 ... Cell Disruptor Industry, 2009-2019 is a professional and ... Disruptor industry. The report firstly reviews the basic ... and manufacturing technology. The report then explores global ... their product specification, capacity, Production value, and market ...
    (Date:8/30/2014)... Beach, Calif. (PRWEB) August 30, 2014 Insomnia ... Francis helps listeners understand how they unknowingly developed insomnia and ... have restful nights during. Tune in to the show ... The show airs live on August 30, and will ... more information on programming, go to DrCarolFrancisTalkRadio.com. , ...
    Breaking Medicine News(10 mins):Health News:Panic Away Review Reveals New Natural Remedy for Anxiety Patients 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 3Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 4Health News:Cradle of Aviation Museum Opens Its Doors to Long Island Scientologists 2Health News:Cell Disruptor Industry Global and Chinese Analysis for 2009-2019 in New Research Report at ReportsnReports.com 2Health News:Cell Disruptor Industry Global and Chinese Analysis for 2009-2019 in New Research Report at ReportsnReports.com 3Health News:Cell Disruptor Industry Global and Chinese Analysis for 2009-2019 in New Research Report at ReportsnReports.com 4Health News:Sleepless Nights, Exhausting Days, Mental Fog – Relief for Insomnia With Clinical Psychologist Dr. Carol Francis 2
    ... and a,presiding judge are among the who,s who of ... Los Angeles to discuss emerging asbestos,litigation trends and lessons ... Berkes of Berkes Crane Robinson & Seal of Los ... Kazan of Kazan McClain,Abrams Lyons Greenwood & Harley of ...
    ... Md., Feb. 19 It was a quiet day at ... playful daggers employees shot at each other throughout the day. ... Speaks in order to silence one co-worker for the day. ... each for the charity. The unusually quiet day raised more ...
    ... Continues, Watson Wyatt/National Business Group on Health Survey FindsWASHINGTON, ... increases to hold steady at 6 percent and more ... in an effort to control cost increases, according to ... consulting firm, and the National Business Group on Health, ...
    ... Champion for BabiesNEW YORK, Feb. 19 The March of Dimes ... MVP, Eli Manning , will return for a second year, to ... will be joined by CBS 2 News Co-Anchor, Maurice DuBois ... who will co-host the morning program. "I,m very excited to be ...
    ... An error in the most recent,edition of the ... Monroe,Hospital callers to an entirely different kind of service ... schedule their next,appointment instead found they could get anything ... , Both an advertisement and ...
    ... health focuses on those aged 18 to 29 , , THURSDAY, ... lack of insurance coverage are among the many health challenges ... special section on young adults between the ages of 18 ... nation,s health from the U.S. Centers for Disease Control and ...
    Cached Medicine News:Health News:California Attorneys Featured at Major Asbestos Litigation Event 2Health News:Travel Advantage Network Enjoys Silencing Co-Workers, Raising More Than $1,600 for Autism 2Health News:Health Care Benefit Cost Increases to Remain at 6 Percent in 2009 2Health News:Health Care Benefit Cost Increases to Remain at 6 Percent in 2009 3Health News:Eli Manning to Lead March for Babies(R) in Manhattan 2Health News:Monroe Hospital: Laughter is Best Medicine for Unwelcome Publicity 2Health News:Obesity, Lack of Insurance Take Toll on Young Americans 2
    ... is the ideal system for fast, accurate filling ... driven, pinch valve controlled dispensing mechanism, ensures that ... of the components that come into contact with ... and autoclave. The unique compact design saves valuable ...
    ... The QFill2 is the ideal system for ... plates. The pressure driven, pinch valve controlled dispensing ... system. Whilst all of the components that come ... to dismantle, clean, and autoclave. The unique compact ...
    ... Fill offers ... and reliable alternative ... dispensers. Fill guarantees ... dispensing without the ...
    ... Multidrop DW is a high-speed automated dispenser for ... 96-well plates. Designed for accuracy and precision, the ... It covers a volume range of 20-995 l. ... high-precision peristaltic pump to dispense directly from single ...
    Medicine Products: